Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

The Molecular Genetics of Mycolic Acid Biosynthesis.

Pawełczyk J, Kremer L.

Microbiol Spectr. 2014 Aug;2(4):MGM2-0003-2013. doi: 10.1128/microbiolspec.MGM2-0003-2013. Review.

PMID:
26104214
3.
4.

Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.

Nataraj V, Varela C, Javid A, Singh A, Besra GS, Bhatt A.

Mol Microbiol. 2015 Oct;98(1):7-16. doi: 10.1111/mmi.13101. Epub 2015 Jul 30. Review.

5.

Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors.

Duan X, Xiang X, Xie J.

FEMS Microbiol Lett. 2014 Nov;360(2):87-99. doi: 10.1111/1574-6968.12597. Epub 2014 Oct 21. Review.

6.

Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.

Schroeder EK, de Souza N, Santos DS, Blanchard JS, Basso LA.

Curr Pharm Biotechnol. 2002 Sep;3(3):197-225. Review.

PMID:
12164478
7.

Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.

Takayama K, Wang C, Besra GS.

Clin Microbiol Rev. 2005 Jan;18(1):81-101. Review.

8.

The β-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets.

Singh V, Mani I, Chaudhary DK, Somvanshi P.

Curr Med Chem. 2011;18(9):1318-24. Review.

PMID:
21370994
9.

Mycolic acids: structures, biosynthesis, and beyond.

Marrakchi H, Lanéelle MA, Daffé M.

Chem Biol. 2014 Jan 16;21(1):67-85. doi: 10.1016/j.chembiol.2013.11.011. Epub 2013 Dec 26. Review.

10.

[Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].

Luo H, Pang L, Xie J.

Wei Sheng Wu Xue Bao. 2012 Feb 4;52(2):146-51. Review. Chinese.

PMID:
22586991
11.

Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.

de Souza MV, Ferreira Mde L, Pinheiro AC, Saraiva MF, de Almeida MV, Valle MS.

ScientificWorldJournal. 2008 Jul 31;8:720-51. doi: 10.1100/tsw.2008.99. Review.

12.

Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems.

Schweizer E, Hofmann J.

Microbiol Mol Biol Rev. 2004 Sep;68(3):501-17, table of contents. Review.

13.

Targeting the mycobacterial envelope for tuberculosis drug development.

Favrot L, Ronning DR.

Expert Rev Anti Infect Ther. 2012 Sep;10(9):1023-36. doi: 10.1586/eri.12.91. Review.

14.

The Role of Biotin in Bacterial Physiology and Virulence: a Novel Antibiotic Target for Mycobacterium tuberculosis.

Salaemae W, Booker GW, Polyak SW.

Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.VMBF-0008-2015. Review.

PMID:
27227307
15.

[Mycolic acids--biological role and potential application in Mycobacterium detection and differentiation].

Kowalski K, Trzepiński P, Druszczyńska M, Boratyński J.

Postepy Hig Med Dosw (Online). 2014 Apr 4;68:350-8. doi: 10.5604/17322693.1097425. Review. Polish.

16.

Targeting the formation of the cell wall core of M. tuberculosis.

Barry CE, Crick DC, McNeil MR.

Infect Disord Drug Targets. 2007 Jun;7(2):182-202. Review.

17.

An approach for the rational design of new antituberculosis agents.

Pasqualoto KF, Ferreira EI.

Curr Drug Targets. 2001 Dec;2(4):427-37. Review.

PMID:
11732641

Supplemental Content

Support Center